SG11201603091QA - Ferric citrate for reducing cardiac failure in chronic kidney disease patients - Google Patents
Ferric citrate for reducing cardiac failure in chronic kidney disease patientsInfo
- Publication number
- SG11201603091QA SG11201603091QA SG11201603091QA SG11201603091QA SG11201603091QA SG 11201603091Q A SG11201603091Q A SG 11201603091QA SG 11201603091Q A SG11201603091Q A SG 11201603091QA SG 11201603091Q A SG11201603091Q A SG 11201603091QA SG 11201603091Q A SG11201603091Q A SG 11201603091QA
- Authority
- SG
- Singapore
- Prior art keywords
- kidney disease
- chronic kidney
- disease patients
- ferric citrate
- cardiac failure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899866P | 2013-11-04 | 2013-11-04 | |
| PCT/US2014/063643 WO2015066593A1 (en) | 2013-11-04 | 2014-11-03 | Ferric citrate for reducing cardiac failure in chronic kidney disease patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201603091QA true SG11201603091QA (en) | 2016-05-30 |
Family
ID=53005244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201603091QA SG11201603091QA (en) | 2013-11-04 | 2014-11-03 | Ferric citrate for reducing cardiac failure in chronic kidney disease patients |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20160256486A1 (enExample) |
| EP (2) | EP3747432A1 (enExample) |
| JP (3) | JP2016535780A (enExample) |
| KR (1) | KR102392441B1 (enExample) |
| CN (1) | CN105873583A (enExample) |
| AU (1) | AU2014341975A1 (enExample) |
| BR (1) | BR112016009901A8 (enExample) |
| CA (1) | CA2928200A1 (enExample) |
| EA (1) | EA201690926A1 (enExample) |
| HK (1) | HK1223031A1 (enExample) |
| IL (1) | IL245317A0 (enExample) |
| MX (1) | MX2016005734A (enExample) |
| SG (1) | SG11201603091QA (enExample) |
| TW (2) | TWI744215B (enExample) |
| WO (1) | WO2015066593A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010276242B2 (en) | 2009-07-21 | 2014-05-29 | Keryx Biopharmaceuticals, Inc. | Ferric citrate dosage forms |
| DK3287133T3 (da) | 2013-06-05 | 2019-07-01 | Tricida Inc | Proton-bindende polymerer til oral indgivelse |
| WO2015198304A1 (en) | 2014-06-22 | 2015-12-30 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| KR102625115B1 (ko) | 2014-12-10 | 2024-01-12 | 트리시다, 인크. | 경구 투여용 양성자-결합 폴리머 |
| KR102655774B1 (ko) | 2016-05-06 | 2024-04-05 | 트리시다, 인크. | 산-염기 장애의 치료를 위한 조성물 및 방법 |
| IL319146A (en) | 2017-11-03 | 2025-04-01 | Tricida Inc | Compositions for and method of treating acid-base disorders |
| CA3117071A1 (en) | 2018-10-29 | 2020-05-07 | Pharmacosmos Holding A/S | Treating iron deficiency with ferric carboxymaltose |
| CN114286682A (zh) * | 2019-02-09 | 2022-04-05 | 法码科思莫斯控股有限公司 | 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁 |
| TW202313072A (zh) * | 2021-05-27 | 2023-04-01 | 美商凱立克斯生物製藥股份有限公司 | 檸檬酸鐵之兒科調配物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE351366B (enExample) * | 1965-06-08 | 1972-11-27 | Teikoku Hormone Mfg Co Ltd | |
| US20050203169A1 (en) * | 2001-08-06 | 2005-09-15 | Moskowitz David W. | Methods and compositions for treating diseases associated with excesses in ACE |
| US8093423B2 (en) | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| MX2008002360A (es) * | 2005-08-18 | 2008-04-29 | Globoasia Llc | Compuestos organicos ferricos grado farmaceutico, uso de los mismos y metodos para elaborar los mismos. |
| KR20080106506A (ko) * | 2006-01-30 | 2008-12-08 | 글로보아시아 엘엘씨 | 만성 신장병의 치료 방법 |
| CN101374416A (zh) * | 2006-01-30 | 2009-02-25 | 环亚有限公司 | 逆转、防止、延迟或稳定软组织钙化的方法 |
| AU2010276242B2 (en) * | 2009-07-21 | 2014-05-29 | Keryx Biopharmaceuticals, Inc. | Ferric citrate dosage forms |
| EP2590655B1 (en) * | 2010-07-07 | 2015-06-24 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| US20130345303A1 (en) * | 2012-06-21 | 2013-12-26 | Keryx Biopharmaceuticals, Inc. | Use of ferric citrate in the treatment of chronic kidney disease patients |
-
2014
- 2014-11-03 EP EP20173867.1A patent/EP3747432A1/en active Pending
- 2014-11-03 KR KR1020167014000A patent/KR102392441B1/ko active Active
- 2014-11-03 CA CA2928200A patent/CA2928200A1/en not_active Abandoned
- 2014-11-03 HK HK16111332.6A patent/HK1223031A1/zh unknown
- 2014-11-03 AU AU2014341975A patent/AU2014341975A1/en not_active Abandoned
- 2014-11-03 JP JP2016552432A patent/JP2016535780A/ja active Pending
- 2014-11-03 CN CN201480072217.1A patent/CN105873583A/zh active Pending
- 2014-11-03 SG SG11201603091QA patent/SG11201603091QA/en unknown
- 2014-11-03 EP EP14858106.9A patent/EP3065734A4/en not_active Ceased
- 2014-11-03 US US15/031,678 patent/US20160256486A1/en not_active Abandoned
- 2014-11-03 EA EA201690926A patent/EA201690926A1/ru unknown
- 2014-11-03 WO PCT/US2014/063643 patent/WO2015066593A1/en not_active Ceased
- 2014-11-03 BR BR112016009901A patent/BR112016009901A8/pt not_active Application Discontinuation
- 2014-11-04 TW TW103138244A patent/TWI744215B/zh active
- 2014-11-04 TW TW110136784A patent/TW202203910A/zh unknown
-
2015
- 2015-01-29 MX MX2016005734A patent/MX2016005734A/es unknown
-
2016
- 2016-04-27 IL IL245317A patent/IL245317A0/en unknown
-
2018
- 2018-12-11 US US16/216,772 patent/US20190307791A1/en not_active Abandoned
-
2019
- 2019-07-31 JP JP2019140640A patent/JP6828100B2/ja active Active
-
2021
- 2021-01-20 JP JP2021007091A patent/JP2021073230A/ja active Pending
-
2024
- 2024-12-31 US US19/006,830 patent/US20250360167A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015066593A1 (en) | 2015-05-07 |
| BR112016009901A8 (pt) | 2020-04-14 |
| IL245317A0 (en) | 2016-06-30 |
| TW201609088A (zh) | 2016-03-16 |
| KR102392441B1 (ko) | 2022-05-02 |
| TWI744215B (zh) | 2021-11-01 |
| US20250360167A1 (en) | 2025-11-27 |
| HK1223031A1 (zh) | 2017-07-21 |
| KR20160096597A (ko) | 2016-08-16 |
| JP2021073230A (ja) | 2021-05-13 |
| EP3065734A4 (en) | 2017-05-17 |
| EP3065734A1 (en) | 2016-09-14 |
| JP2016535780A (ja) | 2016-11-17 |
| CN105873583A (zh) | 2016-08-17 |
| US20190307791A1 (en) | 2019-10-10 |
| EA201690926A1 (ru) | 2016-09-30 |
| CA2928200A1 (en) | 2015-05-07 |
| EP3747432A1 (en) | 2020-12-09 |
| JP6828100B2 (ja) | 2021-02-10 |
| AU2014341975A1 (en) | 2016-05-19 |
| US20160256486A1 (en) | 2016-09-08 |
| JP2019206562A (ja) | 2019-12-05 |
| MX2016005734A (es) | 2016-11-08 |
| TW202203910A (zh) | 2022-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL236356A0 (en) | Use of iron citrate to treat patients with chronic kidney disease | |
| SG11201603091QA (en) | Ferric citrate for reducing cardiac failure in chronic kidney disease patients | |
| GB2585392B (en) | System and method for performing alternative and sequential blood and peritoneal dialysis modalities | |
| EP3862044C0 (en) | TWO-TIP HEMODIALYSIS CATHETER | |
| IL242804B (en) | Pridopidine to reduce functional decline in Huntington's patients | |
| IL245211A0 (en) | an inhaler for the medicine | |
| AU353289S (en) | Patient interface | |
| EP2833957A4 (en) | THERAPY FOR CHILDREN'S DISEASE AND / OR HEART FAILURE THROUGH INTRADERMAL INFUSION | |
| ZA201501977B (en) | Orally administered medical composition | |
| GB201314512D0 (en) | Dual Haemodialysis and Haemodiafiltration blood treatment device | |
| EP2990040A4 (en) | Therapeutic agent for eyeground disease | |
| LT2958624T (lt) | Transplantuotų pacientų transplantanto prieš šeiminiką ligos gydymas | |
| SG11201601490XA (en) | Risk markers for cardiovascular disease in patients with chronic kidney disease | |
| PL2875049T3 (pl) | Sposoby zapobiegania i leczenia przewlekłej choroby nerek (ckd) | |
| GB201305761D0 (en) | Blood Pump | |
| IL240218B (en) | Catheter for blockage between a nerve and an organ | |
| GB201305758D0 (en) | Blood Pump | |
| EP2959905A4 (en) | ORAL ADMINISTRATIVE ADSORBENT, THERAPEUTIC AGENT AGAINST CHILDING DISEASE AND THERAPEUTIC AGENT AGAINST LIVER DISEASES | |
| EP2959906A4 (en) | ADSORBENT FOR ORAL ADMINISTRATION, MEDICAMENT FOR RENAL DISEASE, AND MEDICAMENT FOR LIVER DISEASE | |
| EP2959908A4 (en) | ORAL ADMINISTRATIVE ADSORBENT, THERAPEUTIC AGENT AGAINST CHILDING DISEASE AND THERAPEUTIC AGENT AGAINST LIVER DISEASES | |
| EP2959907A4 (en) | ADSORBENT FOR ORAL ADMINISTRATION, MEDICAMENT FOR RENAL DISEASE, AND MEDICAMENT FOR LIVER DISEASE | |
| EP3217987A4 (en) | Sglt-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease | |
| HUE071419T2 (hu) | Gyógyászati szénhidrát készítmény terápiás alkalmazásra | |
| PT3007772T (pt) | Composições para utilização no tratamento de dislipidemia em doença renal crónica | |
| PL2849835T3 (pl) | Nietymczasowy centralny cewnik żylny do stosowania w hemodializie |